Zhi Dan Jia

Presidente presso Sinopharm YiXin Pharmaceutical Co., Ltd.

63 anni

Health Technology

Profilo

Zhi Dan Jia is currently the Chairman at Sinopharm YiXin Pharmaceutical Co., Ltd.
Prior to this, he worked as the General Manager & Director at Shanghai Shyndec Pharmaceutical Co., Ltd.

Posizioni attive di Zhi Dan Jia

Società	Posizione	Inizio
Sinopharm YiXin Pharmaceutical Co., Ltd. Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China.	Presidente	-

Tutte le posizioni attive di Zhi Dan Jia

Precedenti posizioni note di Zhi Dan Jia

Società	Posizione	Fine
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Zhi Dan Jia

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Zhi Dan Jia

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Health Technology

Aziende private	1
Sinopharm YiXin Pharmaceutical Co., Ltd. Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China.	Health Technology